Dublin, July 15, 2020 (GLOBE NEWSWIRE) -- The "Vernal Keratoconjunctivitis (VKC) Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an ...

DUBLIN--(BUSINESS WIRE)--The "Vernal Keratoconjunctivitis (VKC) Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth ...

Verkazia is an oil-in-water cationic emulsion that works by inhibiting T-cell activation and reducing the level of immune cells and mediators. Verkazia ® (cyclosporine ophthalmic emulsion) 0.1% is now ...

Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye. The Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . MILAN — In this video perspective at the ESCRS meeting, Dominique Brémond-Gignac, MD, PhD, speaks about ...

Please provide your email address to receive an email when new articles are posted on . Steroid-induced glaucoma was more likely with at least 6 months of use, higher potency and urban residence.

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic condition primarily affecting children and young adults. It is a seasonal allergic inflammatory disease of the eye with episodes of ...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Vernal Keratoconjunctivitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...

"Vernal keratoconjunctivitis Pipeline"DelveInsight's,“Vernal Keratoconjunctivitis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Vernal ...

(MENAFN- GlobeNewsWire - Nasdaq) The VKC market is expanding due to increasing allergic ocular diseases, awareness, and access to therapies. Opportunities lie in Asia Pacific and the Middle East, ...